AstraZeneca Plc investors had a clear message for the UK drugmaker on Monday: they don’t like the idea of a $400 billion merger with Bristol-Myers Squibb Co. Bloomberg Intelligence's Director of Research, Sam Fazeli joins to discuss.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/videos/2026-08-03/astrazeneca-investors-see-little-logic-in-bristol-tie-up-video)